scholarly article | Q13442814 |
P2093 | author name string | Hendrik Lehnert | |
Harpal S Randeva | |||
Bee K Tan | |||
Paul O'Hare | |||
Raghu Adya | |||
Kris C Lewandowski | |||
S Farhatullah | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
insulin resistance | Q1053470 | ||
polycystic ovary | Q5547896 | ||
preproinsulin | Q7240673 | ||
polycystic ovary syndrome | Q500816 | ||
P304 | page(s) | 801-808 | |
P577 | publication date | 2008-01-03 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose | |
P478 | volume | 57 |
Q45354242 | A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism |
Q36972589 | Adipokines and insulin resistance |
Q38014474 | Adipokines and the cardiovascular system: mechanisms mediating health and disease |
Q26852200 | Adipokines as a novel link between obesity and atherosclerosis |
Q90221587 | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease |
Q39390964 | Adipose Tissue-Derived Omentin-1 Function and Regulation |
Q92816040 | Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs |
Q64076542 | Altered circulating levels of adipokine omentin-1 in patients with prostate cancer |
Q37718879 | Analysis of pericardial effusion from idiopathic pericarditis patients by two-dimensional gel electrophoresis. |
Q60309676 | Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients? |
Q42340178 | Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome |
Q89458033 | Association of Omentin-1 with Oxidative Stress and Clinical Significances in Patients with Breast Cancer |
Q44167178 | Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. |
Q90166059 | Association of circulating adipokine concentrations with indices of adiposity and sex in healthy, adult client owned cats |
Q35607765 | Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. |
Q38644618 | Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review |
Q92382974 | Autocrine action of adipokine omentin-1 in the SW480 colon cancer cell line |
Q35040658 | BAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity |
Q36929499 | Cardiac Affection in Type 1 Diabetic Patients in Relation to Omentin. |
Q34651892 | Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. |
Q36786928 | Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients |
Q83366731 | Circulating omentin as a novel biomarker of endothelial dysfunction |
Q33810842 | Circulating omentin concentration increases after weight loss |
Q51292125 | Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis. |
Q28477087 | Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue |
Q40578414 | Detraining-induced alterations in adipokines and cardiometabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men. |
Q51295458 | Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? |
Q35323904 | Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients |
Q43026599 | Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. |
Q92344339 | Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review |
Q36686554 | Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome |
Q37514552 | Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease |
Q38983232 | Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT. |
Q37382304 | Features of omental adipose tissue in endometrial cancer patients with 'standard' or 'metabolically healthy' obesity: associations with tumor process characteristics |
Q38170410 | Gestational diabetes mellitus and cardiovascular risk after pregnancy. |
Q97568720 | ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment |
Q40435027 | Impact of olive oil-rich diet on serum omentin and adiponectin levels: a randomized cross-over clinical trial among overweight women. |
Q33552771 | Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure |
Q64085183 | Impact of serum omentin-1 levels on functional prognosis in nondiabetic patients with ischemic stroke |
Q53335886 | Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. |
Q64085301 | Independent and Combined Effects of Antioxidant Supplementation and Circuit Resistance Training on Selected Adipokines in Postmenopausal Women |
Q34089724 | Inflammation, a Link between Obesity and Cardiovascular Disease |
Q38132102 | Management of reproduction and pregnancy complications in maternal obesity: which role for dietary polyphenols? |
Q48239083 | Maternal and neonatal omentin-1 levels in gestational diabetes. |
Q89980510 | Maternal omentin-1 level, quality of life and marital satisfaction in relation to mode of delivery: a prospective cohort study |
Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
Q34355173 | Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome |
Q38209810 | Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role? |
Q36349750 | New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study |
Q33884054 | New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women |
Q28079661 | Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome |
Q36138940 | Omentin as a novel biomarker of metabolic risk factors |
Q34079744 | Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease |
Q43780126 | Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis |
Q34404890 | Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity |
Q30371628 | Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation. |
Q36245527 | Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1: impact of weight reduction. |
Q96430987 | Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis |
Q26766485 | Pancreatic regulation of glucose homeostasis |
Q35758876 | Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China |
Q47190662 | Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome |
Q38864973 | Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI. |
Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
Q41574249 | Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development |
Q91274436 | Serum Adipokine Levels in Patients Considered for Lung Transplantation |
Q47670217 | Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation. |
Q35581618 | Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes |
Q38612064 | Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome |
Q64900838 | Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters. |
Q46074545 | Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease |
Q35740949 | Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients |
Q33849140 | The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women |
Q92618367 | The association between Chinese patients' elevated omentin-1 levels, their clinicopathological features, and the risk of colorectal cancer |
Q51409818 | The association of Val109Asp polymorphic marker of intelectin 1 gene with abdominal obesity in Kyrgyz population. |
Q91810395 | The endocrine function of adipose tissues in health and cardiometabolic disease |
Q51276844 | The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity. |
Q53682459 | The role of adipokines in skeletal muscle inflammation and insulin sensitivity. |
Q51371275 | Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. |
Search more.